Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Accro Bioscience (suzhou) Limited

Clinical trials sponsored by Accro Bioscience (suzhou) Limited, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill AC-003 tested for severe transplant complication Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

New pill AC-003 tested for severe transplant complication

Disease control Recruiting now

This early-phase trial is testing an experimental drug called AC-003 in 24 adults who have acute graft-versus-host disease (aGVHD) after a stem cell transplant and whose condition has not improved with steroids. The study aims to see if the drug is safe and tolerable, and to get …

Phase 1 • Sponsor: Accro Bioscience (Suzhou) Limited • Aim: Disease control

Last updated Jun 27, 2026 11:02 UTC